Group items matching

in title, tags, annotations or url

Cutting the red tape that blocks pharmacists to alter the HRT prescription could 'quickly fix' the problem of women unable to access their HRT medicines, the Royal Pharmaceutical Society (RPS) told Daily Mail. RPS has suggested that allowing pharmacists to prescribe alternative HRT treatment amid nationwide shortage of HRT medicine could help the women who are struggling to access these medicines. Thorrun Govind, chair of the English Pharmacy Board, told MailOnline 'changes in prescription rules need to be changed urgently.' She added, 'For the pharmacists on the ground, they need the ability to get rid of this bureaucracy. When you think about it - who's best able to offer an alternative - that tends to be the pharmacist.' MailOnline quoted Professor Claire Anderson, president of the Royal Pharmaceutical Society, as said, 'We welcome the Health Secretary meeting with key suppliers and manufacturers to find solutions to the current shortages. But cutting the red tape holding pharmacists back could provide a 'quick fix' that would allow 'women to access their HRT medicines more speedily'.

The Royal Pharmaceutical Society has opened a survey which asks its members how they would want to take part in and learn about decisions made by the RPS. The RPS said the survey was a core part of the independent review of member participation and communications led by communications consultancy Luther Pendragon. It said: "We will be asking our members to join focus groups to give their opinions on how participation can be developed and strengthened, and how RPS communications about decisions it has taken on behalf of the profession through its governance boards can be improved. We will also be asking our elected members and key external stakeholders for their views over the coming weeks." The Luther team will then build a series of recommendations for RPS and develop a corporate communications strategy which will include action plans to enable greater participation. RPS president Claire Anderson said: "We want to hear from as many of you as possible through our survey to inform how the organisation works with and engages with you, our members.

From the informative to the fascinating, the collection of exhibits that make up the Royal Pharmaceutical Society's (RPS) museum collection reopened at the Society's London headquarters on Monday (May 16). The museum, which has been closed to the public for two years, boasts one of the largest collections of historical pharmacy exhibits in the country. The 181-year-old museum features a host of amazing objects from the 1400s up to the present day that dramatically illustrate just how far modern medicine has come. From poison bottles and medieval textbooks, to trade tokens and pottery, the museum is there for everybody. Museum exhibits include finding out about ceramic 'bear' jars containing bear oil, which was once thought to be a remedy for baldness, exploring what nineteenth Century 'asthma cigarettes' were used for, and finding out why a stuffed Nile crocodile was the symbol for the apothecary. The museum showcases the unique history of the development of drugs for medical treatment, alongside the evolution of the pharmacy profession in Britain, and the role RPS played in its development.

The Royal Pharmaceutical Society (RPS) has re-joined the International Pharmaceutical Federation (FIP) after reflecting its commitment to international collaboration and the advancement of the pharmacy profession. RPS President Professor Claire Anderson said: "Members told us they wanted to see us re-join FIP to further our commitment to international partnerships which support education and advocacy to develop and progress the pharmacy profession.". "We fully recognise the importance of international collaboration and the sharing of knowledge and best practice with our peers across the world. "FIP are refocusing their membership offer and we're delighted to work with them on opportunities for professional development and increased visibility and recognition for the pharmacy profession." Paul Bennett, RPS CEO said: "Now that we have re-joined, our teams across RPS look forward to reinvigorating the close collaboration we have previously enjoyed with our colleagues both within FIP itself, and across the breadth of FIP Member organisations to further our vision and mission".

Nine in ten people surveyed by Ipsos on behalf on NHS positively rated the advice they received from their local pharmacies. The results from Ipsos found that the vast majority of patients (91%) who had used a community pharmacy in the previous year for advice about medicines, a health problem or injury, or what health service they should use said they received good advice. The research comes as more than 11,000 pharmacies in England can now access training to spot signs of cancer as part of a new drive to catch tumours earlier when they are easier to treat. Thorrun Govind, Chair of the Royal Pharmaceutical Society English Pharmacy Board, said: "Community pharmacists are working exceptionally hard to make sure that the public gets the right advice at the right time. This new data shows the public appreciate both the accessibility and quality of advice they receive from community pharmacists. "I am delighted that the Royal Pharmaceutical Society is working with the NHS to deliver professional development for community pharmacists to further enhance their clinical consultation skills.

The Royal Pharmaceutical Society (RPS) has updated the Professional Standards for Homecare Services to ensure high quality care for patients receiving medicines and associated services in the comfort of their own homes. Originally published in 2013, these standards provide a comprehensive framework to support teams involved in planning, commissioning, and delivering homecare services. The RPS said that these standards were updated to ensure that they align with the needs and expectations of recipients of homecare services, as well as commissioners and providers. Changes were made based on responses received through a consultation process, which was participated by representatives from the National Homecare Medicines Committee, the Association of Pharmacy Technicians, the Pharmacy Forum of Northern Ireland, and the Royal College of Nursing.

Several pharmacies have joined the inhaler recycling scheme in Wolverhampton, West Midlands, to support NHS England's Greener NHS programme, which aims to achieve net zero emissions by 2040. It is part of a collaborative working initiative between the Royal Wolverhampton NHS Trust and AstraZeneca UK Ltd, supported by the Black Country Integrated Care Board and Wolverhampton City Local Pharmaceutical Committee. Under this scheme, old and used inhalers are recycled and transformed into new products, such as coat hangers and waste bins. Simon Evans, group chief strategy officer for The Royal Wolverhampton NHS Trust, emphasised the importance of prioritising the reduction of carbon footprint while maintaining high-quality care, to protect the planet for future generations. "The Trust has already made significant achievements in several areas including the physical estate, clinical services, waste recycling, catering and medicines - with this inhaler recycling scheme from pharmacy being the latest string to our bow," he said.

The Royal Pharmaceutical Society (RPS) has introduced a new comprehensive learning programme to support pharmacists in Wales to deliver the Pharmacy Independent Prescribing Service (PIPS). Developed in collaboration with Health Education and Improvement Wales (HEIW), the programme is designed to "equip pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care." While the primary emphasis is on pharmacists operating within primary care settings, those from various practice settings are also encouraged to register and participate in the programme. Commenting on the collaboration with HEIW, Elen Jones, director for Wales at the Royal Pharmaceutical Society, said that it will empower pharmacists across the country to deliver high-quality prescribing services to local communities.

The Royal Pharmaceutical Society (RPS) has announced the results of the 2024 elections for its three national Pharmacy Boards. For the English Pharmacy Board, the newly elected members include Claire Anderson, Martin Astbury, Steve Churton, Ciara Duffy, Sue Ladds, Mike Maguire, Tase Oputu and Ankish Patel. Matthew Prior has been elected for a period of one year to fill the casual vacancy on the Board. Seven candidates have been elected unopposed to the RPS Scottish Pharmacy Board. They include: Jonathan Burton, Lucy Dixon, Laura Fulton, Catriona Sinclair, Amina Slimani-Fersia, Richard Strang and Audrey Thompson. Only seven nominations were received for the eight substantive vacancies on the board. Helen Davies has been elected to the RPS Welsh Pharmacy Board to represent the Primary Care sector. Meanwhile, Rafia Jamil and Geraldine McCaffrey have been elected unopposed to fill the two vacancies in the Hospital sector.

As part of its inclusion and diversity strategy, the Royal Pharmaceutical Society (RPS) has launched a campaign to challenge barriers to working in pharmacy for those with disabilities. A profession-wide survey on the subject conducted by the RPS, identified disability as the biggest barrier to working in pharmacy, highlighting the area of work to support pharmacists. The campaign will focus on reducing barriers to enter the profession, developing more accessible working environments and encouraging employers to collect data on disability in the workplace. The campaign, based on inputs from the RPS Ability Group volunteers with visible and non-visible disabilities, will run until the end of March. Following recommendation of the RPS Ability Group, RPS has written to the General Pharmaceutical Council (GPhC) the Higher Education Occupational Practitioners (HEOPS) to update the guidance on standards of medical fitness for pharmacy students.

The Royal Pharmaceutical Society (RPS) Assembly has announced the re-appointment of Professor Claire Anderson as President for a further term of two years on Tuesday (11 July). As president, Anderson will oversee delivery and implementation of the constitutional governance review; continue to extend the profile and influence of pharmacy as a profession by building and strengthening relationships with all the other pharmacy leadership bodies and organisations. She aims to ensure that RPS is invited to the table whenever medicines and public health are discussed by continuing to invest in strategic relationships beyond pharmacy Claire was first elected as President in 2021. In her address to the Assembly, Claire said: "This is a time of unprecedented change and I have decided to stand as President for a second term to offer much needed continuity. "I am passionate about our profession and committed to making the RPS and our members even more successful. I will also continue to be a dedicated ambassador and advocate for the profession nationally and internationally."

The Royal Pharmaceutical Society (RPS) has re-elected Andrew Carruthers as chair of RPS Scotland Pharmacy Board. Andrew is a Medicines Governance pharmacist within NHS Greater Glasgow and Clyde, where he has a clinical commitment to Care of the Elderly. Prior to becoming a pharmacist, he studied Pharmacology at the University of Glasgow, and maintains a keen interest in pharmacokinetics and research. In his address for the position, he said: "In my second term I want to continue to support and drive the introduction of RPS Ambassadors and the creation of an online RPS community." "As a previous RPS local coordinator, I've seen first-hand that RPS Local events are a great forum to formally support the training and development of local pharmacists. With input from our members and RPS staff we could share learning, inspire, and enable development, and build a supportive online community for the profession." He was the RPS Local Co-ordinator for Greater Glasgow and Clyde for 3 years, then he co-opted on to the Scottish Pharmacy Board (SPB) in 2018 and have been an active and effective member of the board. He was re-elected to the board in 2021 and he stood and was elected as Chair.

NHS England has commissioned the Royal Pharmaceutical Society (RPS) to develop guidance that helps community and hospital pharmacy teams across Britain to reduce the impact of pharmacy services, pharmaceutical care and medicines on the environment. The RPS said the Greener Pharmacy Guidance will enable pharmacies to self-assess their impact against the standards, benchmark and improve through evidence-based activities and actions. "I'm delighted our strong commitment to helping pharmacy reduce its environmental impact can now be taken to the next level through developing guidance and accreditation for pharmacy teams," RPS president Professor Claire Anderson said. "Medicines account for 25 per cent of carbon emissions within the NHS and this initiative underscores our commitment to promoting sustainable healthcare and supporting the NHS's goal of achieving 'net zero' emissions by 2040." Peter Morgan, medicines assistant director at NHS England, commented: "Pharmacy staff are involved in the purchasing and dispensing of almost every medicine used in the NHS and the new Greener Pharmacy Guidance and Self-accreditation scheme will provide support for pharmacy professionals by outlining clear actions to deliver more environmentally sustainable pharmacy practices." The RPS said the guidance and digital self-assessment toolkit will integrate with carbon calculator tools to help pharmacy teams to measure their carbon footprint, action plan to reduce use of carbon and improve sustainability.

The Royal Pharmaceutical Society (RPS) Wales has welcomed proposals from the Welsh government to increase access to PrEP via community pharmacies for people at risk of HIV. The new HIV Action Plan for Wales consultation proposes a shared care model between primary care and specialist sexual health services to improve access to PrEP. Commenting on the proposal, chair of RPS in Wales Cheryl Way said: "Increasing access to the medicines has been a long-standing issue of concern for us at RPS and we're therefore delighted to see the proposals outlined by the Welsh government to develop a model which will enable PrEP to be provided by community pharmacies across Wales. "PrEP are highly effective medicines, that reduce the chances of getting HIV, as proven by the Welsh Government's three year PrEPARED study which found no new diagnoses of HIV among over 1,200 people taking PrEP in Wales. This is clear evidence that PrEP should be made as easily accessible as possible to those who need it.

To support the mental health and wellbeing of pharmacists, the Royal Pharmaceutical Society (RPS) is running its fourth annual Workforce Wellbeing survey, in partnership with Pharmacist Support. This year it's focussed on exploring some of the obstacles that prevent workforce wellbeing measures being implemented in practice. It's vital that workplace supports good mental health and wellbeing and provides the right environment to help prevent the negative effects of working under intense pressure. RPS urges: "Please complete the survey as soon as you can. It's anonymous, open to pharmacists in all settings including students and you don't need to be a member of RPS to take part." "We'll take the results of the survey to governments across Great Britain, the NHS, and wider stakeholders to advocate for improvements to support the mental health and wellbeing of pharmacists."

The Royal Pharmaceutical Society (RPS) has revealed the "differential attainment" gap among Black pharmacy students and Foundation trainees. Research conducted by pharmacy education has revealed unique challenges leading to lower attainment in the registration assessment and an undergraduate awards gap compared to white students. The organisation plans to work with new groups including BPSA, GPhC, NHS England, Pharmacy Schools Council and representatives from Schools of Pharmacy, to achieve a fair and equitable education and training experience for the students. They plan to reach out to student representative organisations to secure their participation in a quarterly meeting of the group. Differential attainment is the unexplained variation between groups who share a protected characteristic, for example, ethnicity, gender and disability.

The Royal Pharmaceutical Society (RPS) has said that it strongly supports the UK government's proposal that individuals born on or after 1 January 2009 should be prohibited from legally purchasing tobacco products. It has also shown its agreement to several other actions proposed by the Department of Health and Social Care's (DHSC) for 'Creating a Smokefree Generation and Tackling Youth Vaping' including: The inclusion of all tobacco products, cigarette papers, and herbal smoking products in the new legislation. Restrictions on the sale and supply of disposable vapes, and vape flavours. RPS President, Professor Claire Anderson, said: "Our recommendations reflect a commitment to creating a future free from the harms of tobacco and youth vaping. It's crucial to prohibit access for the youngest generation, regulate all tobacco-related items, and address the allure of flavoured e-cigarettes."

Royal Pharmaceutical Society (RPS) Scotland has submitted its evidence to the Health, Social Care and Sport Committee's inquiry into 'Healthcare in remote and rural areas.' The Committee had sought views on what policies and actions would be most effective in addressing the issues people face when accessing healthcare in these areas. During the evidence session today (19 December), Laura Wilson, Director for RPS Scotland, highlighted the challenges faced by pharmacists and pharmacy in remote and rural areas, as well as provided some of the solutions for ensuring a sustainable pharmacy workforce. At present, people living in remote and rural areas of Scotland are required to travel to Glasgow or Aberdeen to undertake pharmacy training. Laura underscored the need to develop alternative education and training pathways, such as "grow your own" models, to support remote and rural areas to develop and retain local pharmacists.

The fusion of the unique in-depth understanding of medicines by pharmacists together with the competence to prescribe offers will improve access to care and increase capacity in the health system, said the Royal Pharmaceutical Society (RPS) Director for England Ravi Sharma to Parliament at the Health and Social Care Select Committee's inquiry on workforce on Monday (May 23). However, he also stated that a new workforce strategy must support and harness the skills of pharmacist independent prescribers in clinical care with investment in training, both for new and existing workforce; access to supervisors; protected learning and development time; and commissioning of services to make best use of independent prescribers across care settings, supported by appropriate prescribing budgets in community pharmacy. "We're about to see new generation of pharmacists independent prescribers that will make a huge difference to the clinical role of pharmacists to support patient care, but this must be underpinned by protected learning time and a more ambitious approach to commissioning new services to use their skills," Ravi said. He spoke to MPs in Parliament at the Health and Social Care Select Committee's inquiry on workforce, highlighting the vital contribution of pharmacy teams during the pandemic and called for action to support the current and future workforce. Some of the key issues highlighted in the parliament included, the risk of burnout and the need to help boost staff retention; staff wellbeing, including a zero tolerance of abuse from the public; the importance of professional development and protected learning time to enhance patient care and support rewarding careers; the potential of new pharmacist independent prescribers and the need for investment in the current workforce and the need for better workforce data and a pharmacy workforce strategy.

The Royal Pharmaceutical Society (RPS) presented the best practice award to a pharmacist from NHS Tayside at an event on May 29 which celebrated pharmacy practice across Scotland. The Glasgow event, organised by RPS, brought together pharmacists from across the country to present their own best-practice examples. These included all sectors of pharmacy, including hospital, GP practices, community and specialist settings. Delegates at the event were asked to vote for what they considered to be the winning example of best practice. Alex Matos, specialist clinical pharmacist, won the award for his presentation on 'Implementing Pharmacogenomics in the Stroke Service'. Alex won a £500 bursary for travel and accommodation to the RPS's annual conference in London, where he has been invited to present on his best practice example.